Hints and tips:
...Yesterday, though, Dara Khosrowshahi of Uber wrote to defend the company’s buyback policy, which we’ve criticised recently. It’s a substantive comment, and we’ve included it below....
...“By Friday he was fully in the seat . . . it was very Dara. He does not get flustered, and he likes a challenge.”...
...The move is part of a long-term vision of chief executive Dara Khosrowshahi, who first talked about Uber becoming a wider travel platform in 2018....
...(Ethan Wu) A reply to Uber’s Dara Khosrowshahi Regular readers will recall that I recently wrote several disapproving things about Uber’s buyback plan....
...A recent performance-related bonus paid to chief executive Dara Khosrowshahi highlights the difference between the number of shares traded on markets and the fully-diluted total....
...Uber chief executive Dara Khosrowshahi has received options to buy stock worth about $136mn after hitting a performance target to secure a $120bn valuation for the ride-hailing company....
...Dara Khosrowshahi, chief executive, celebrated the results as “an inflection point for Uber, proving that we can continue to generate strong profitable growth at scale”....
...On Wednesday, Dara Khosrowshahi said: “Make no mistake: we remain committed to executing against our grocery and retail strategy . . ....
...The new claim comes despite efforts by Dara Khosrowshahi, Uber’s chief executive since 2017, to rebuild relations with licensed cab drivers, after the company’s co-founder Travis Kalanick described the industry...
...Last year, chief executive Dara Khosrowshahi claimed that Uber was a business that could produce substantial sums of cash....
...One scoop to start: Uber chief executive Dara Khosrowshahi has received options to buy stock worth about $136mn after hitting a performance target to secure a $120bn valuation for the ride-hailing company...
...Under chief executive Dara Khosrowshahi, Uber has pushed into businesses beyond its core ride-sharing and restaurant delivery segments, including grocery delivery and advertising, which has boosted margins...
...Letter in response to this article:Uber buyback reflects a confidence its best days are yet to come / From Dara Khosrowshahi, Chief Executive, Uber Technologies, San Francisco, CA, US...
...Merck has agreed to buy Prometheus Biosciences for $10.8bn as the US drugmaker bolsters it pipeline ahead of the possible loss of exclusivity over its best-selling cancer drug later this decade....
...Dara Khosrowshahi has come through on his promise to prioritise cash flow. Headcount has dipped and M&A is a rarity. The days of high spending on speculative business ideas are over....
...By squeezing out the company’s first operating profit this quarter, Dara Khosrowshahi, the former Expedia boss who took over six years ago, and Nelson Chai, who came in as chief financial officer to steer...
...“For most of our history profitable wasn’t the first thing that came up when you asked someone about Uber,” chief executive Dara Khosrowshahi admitted on a call with analysts....
...One reason why synthetic tests have not been more widely adopted is a lack of standards on the use of rFC, according to Lonza, the Swiss-based biosciences company which has developed an alternative test....
...On Sunday, Merck announced that it would acquire Prometheus Biosciences for $10.8bn. It is paying Prometheus shareholders a 72 per cent premium over the three-month average share price....
...“Our robust outlook for Q2 extends our track record of delivering strong growth and profitability,” said Uber chief executive Dara Khosrowshahi on Tuesday....
...Privately owned Firmenich last year announced a €41bn plan to merge with the Dutch ingredients and bioscience group DSM, which was approved by DSM shareholders in January....
...“The pandemic’s impact on our mobility business is now well and truly behind us,” chief executive Dara Khosrowshahi told investors, saying he expected “growth and profitability” in the year ahead....
...In January 2020, it was forced to abandon its $1.2bn takeover of rival Pacific Biosciences following opposition from regulators....
...Novavax’s Stanley Erck will be replaced by John C Jacobs, most recently chief executive at Harmony Biosciences, this month; CureVac’s Franz-Werner Haas will be succeeded by Alexander Zehnder, a Sanofi veteran...
...Growth in bookings indicated a “stronger holiday travel season around the world”, said chief executive Dara Khosrowshahi in prepared remarks to investors....
International Edition